Opexa Therapeutics CEO Chris Schelling's 2020 pay falls 54% to $676K
Opexa Therapeutics reports 2020 executive compensation
By ExecPay News
Published: April 16, 2021
Opexa Therapeutics reported fiscal year 2020 executive compensation information on April 16, 2021.
In 2020, three executives at Opexa Therapeutics received on average a compensation package of $567K, a 50% decrease compared to previous year.
Average pay of disclosed executives at Opexa Therapeutics
Chris Schelling, Chief Executive Officer, received $676K in total, which decreased by 54% compared to 2019. 65% of Schelling's compensation, or $436K, was in salary. Schelling also received $240K in bonus.
Harry Palmin, Chief Financial Officer, received a compensation package of $535K, which decreased by 37% compared to previous year. 71% of the compensation package, or $382K, was in salary.
Donald R. Joseph, Chief Legal Officer, earned $490K in 2020.
Related executives
You may also like
Source: SEC filing on April 16, 2021.